Index S&P 500 P/E 18.38 EPS (ttm) 3.16 Insider Own 0.86% Shs Outstand 225.56M Perf Week 2.00%
Market Cap 13.03B Forward P/E 12.53 EPS next Y 4.63 Insider Trans -1.27% Shs Float 222.47M Perf Month -6.80%
Income 744.00M PEG 2.38 EPS next Q 1.02 Inst Own 103.33% Short Float 3.02% Perf Quarter -20.16%
Sales 4.04B P/S 3.23 EPS this Y 4.48% Inst Trans -1.01% Short Ratio 2.43 Perf Half Y -28.60%
Book/sh 21.16 P/B 2.74 EPS next Y 8.71% ROA 8.65% Short Interest 6.71M Perf Year -24.29%
Cash/sh 8.79 P/C 6.61 EPS next 5Y 7.71% ROE 15.78% 52W Range 55.89 - 84.67 Perf YTD -19.43%
Dividend Est. - P/FCF 11.53 EPS past 5Y - ROI 10.24% 52W High -31.40% Beta 0.55
Dividend TTM - Quick Ratio 2.78 Sales past 5Y 6.10% Gross Margin 55.94% 52W Low 3.92% ATR (14) 1.65
Dividend Ex-Date - Current Ratio 3.49 EPS Y/Y TTM 50.25% Oper. Margin 24.19% RSI (14) 42.99 Volatility 1.86% 3.12%
Employees 7063 Debt/Eq 0.53 Sales Y/Y TTM 1.75% Profit Margin 18.42% Recom 2.48 Target Price 76.27
Option/Short Yes / Yes LT Debt/Eq 0.52 EPS Q/Q -15.61% Payout 0.00% Rel Volume 0.57 Prev Close 58.02
Sales Surprise 0.00% EPS Surprise 1.47% Sales Q/Q 0.86% Earnings May 01 AMC Avg Volume 2.76M Price 58.08
SMA20 -1.45% SMA50 -5.13% SMA200 -20.93% Trades
Volume 1,579,261 Change 0.10%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-03-25 Downgrade Argus
Buy → Hold
Feb-06-25 Downgrade Leerink Partners
Outperform → Market Perform
$80 → $75
Feb-03-25 Downgrade Needham
Buy → Hold
Dec-13-24 Initiated Wolfe Research
Peer Perform
Dec-10-24 Reiterated Needham
Buy
$90
Dec-10-24 Initiated Jefferies
Hold
$85
Oct-01-24 Downgrade Citigroup
Buy → Neutral
$95 → $85
Jun-27-24 Initiated Stephens
Overweight
$87
Apr-03-24 Upgrade Citigroup
Neutral → Buy
$80 → $95
Jul-14-23 Upgrade Needham
Hold → Buy
$95
Dec-07-22 Initiated RBC Capital Mkts
Sector Perform
$75
Oct-13-22 Initiated Mizuho
Buy
$75
Jul-20-22 Initiated UBS
Neutral
$73
Jul-20-22 Downgrade BofA Securities
Buy → Neutral
$81 → $75
Jul-18-22 Downgrade BTIG Research
Buy → Neutral
Apr-25-22 Downgrade Wells Fargo
Overweight → Equal Weight
$75
Apr-04-22 Downgrade Evercore ISI
Outperform → In-line
$80
Dec-15-21 Downgrade Citigroup
Buy → Neutral
$85 → $78
Oct-15-21 Resumed Cowen
Outperform
$83
Oct-14-21 Initiated Redburn
Neutral
Show Previous Ratings
Today 09:15AM
08:45AM
Apr-25-25 08:18AM
Apr-24-25 08:10AM
Apr-23-25 09:00AM
10:10AM
Loading…
Apr-22-25 10:10AM
09:03AM
08:08AM
Apr-21-25 05:45PM
Apr-14-25 05:45PM
Apr-11-25 09:00AM
Apr-10-25 05:14AM
Apr-07-25 05:45PM
08:48AM
Apr-04-25 04:15PM
04:30PM
Loading…
Apr-03-25 04:30PM
09:40AM
Mar-31-25 05:45PM
09:00AM
Mar-24-25 05:45PM
Mar-20-25 11:46AM
Mar-19-25 09:57AM
09:00AM
Mar-17-25 05:45PM
Mar-13-25 06:58PM
Mar-10-25 05:01AM
Mar-07-25 11:30AM
09:00AM
Mar-04-25 07:37AM
Feb-26-25 04:01AM
08:15AM
Loading…
Feb-25-25 08:15AM
Feb-24-25 09:00AM
Feb-21-25 12:28PM
08:30AM
Feb-20-25 05:23AM
03:00AM
Feb-19-25 05:16AM
Feb-18-25 08:08AM
Feb-12-25 08:08AM
Feb-11-25 09:15AM
09:00AM
08:12AM
Feb-07-25 09:40AM
07:21AM
Feb-06-25 09:50AM
09:34AM
08:05AM
(Thomson Reuters StreetEvents)
02:13AM
Feb-05-25 05:30PM
05:15PM
04:11PM
(Associated Press Finance)
04:11PM
04:01PM
Feb-04-25 09:40AM
Jan-31-25 09:15AM
09:00AM
Jan-29-25 10:01AM
Jan-28-25 05:45PM
Jan-22-25 05:45PM
Jan-21-25 08:00AM
Jan-20-25 09:00AM
Jan-16-25 06:38AM
Jan-14-25 05:45PM
Jan-12-25 04:00PM
Jan-08-25 05:45PM
Jan-07-25 04:04PM
09:00AM
Jan-06-25 04:15PM
08:05AM
Jan-03-25 06:46AM
Jan-02-25 05:45PM
Dec-26-24 05:45PM
Dec-24-24 09:00AM
Dec-23-24 12:19PM
Dec-19-24 05:45PM
06:45AM
Dec-18-24 08:08AM
Dec-14-24 06:50AM
Dec-13-24 07:10PM
05:45PM
09:00AM
Dec-10-24 11:10PM
04:01PM
Dec-09-24 04:05PM
08:05AM
Dec-04-24 11:30AM
Dec-02-24 01:29PM
08:08AM
Nov-25-24 08:22AM
Nov-19-24 09:00AM
Nov-14-24 08:08AM
Nov-08-24 12:21PM
09:00AM
Nov-05-24 11:43AM
(Morningstar Research) -5.88%
06:35AM
(Thomson Reuters StreetEvents)
02:06AM
Nov-04-24 05:30PM
05:15PM
04:20PM
(Associated Press Finance)
04:01PM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mitchell Essex D Chief Operating Officer Dec 04 '24 Option Exercise 62.60 22,902 1,433,659 52,813 Dec 06 04:28 PM Mitchell Essex D Chief Operating Officer Dec 04 '24 Sale 76.34 24,856 1,897,482 27,957 Dec 06 04:28 PM Mitchell Essex D Officer Dec 04 '24 Proposed Sale 76.34 24,856 1,897,484 Dec 04 12:24 PM Oberton Karleen Marie Chief Financial Officer Aug 29 '24 Option Exercise 40.95 32,805 1,343,214 136,721 Sep 03 04:15 PM Oberton Karleen Marie Chief Financial Officer Aug 29 '24 Sale 80.56 52,679 4,243,662 84,042 Sep 03 04:15 PM Oberton Karleen Marie Officer Aug 29 '24 Proposed Sale 80.56 52,679 4,243,657 Aug 29 04:36 PM Schnittker Brandon Div. President, GYN Surgical Aug 06 '24 Sale 83.11 476 39,559 3,735 Aug 08 04:08 PM Schnittker Brandon Officer Aug 06 '24 Proposed Sale 83.11 476 39,559 Aug 06 04:48 PM COHN BENJAMIN JORDAN Principal Accounting Officer Aug 01 '24 Sale 81.99 5,093 417,570 10,476 Aug 05 04:29 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 30 '24 Option Exercise 26.21 44,039 1,154,262 1,201,601 Aug 01 04:09 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 30 '24 Sale 81.70 44,039 3,597,924 1,157,562 Aug 01 04:09 PM COHN BENJAMIN JORDAN Officer Aug 01 '24 Proposed Sale 81.99 5,093 417,574 Aug 01 03:58 PM MACMILLAN STEPHEN P Officer Jul 30 '24 Proposed Sale 81.70 44,039 3,597,894 Jul 30 04:29 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 17 '24 Option Exercise 26.21 3,672 96,243 1,161,234 Jul 19 04:09 PM MACMILLAN STEPHEN P Chairman, President and CEO Jul 17 '24 Sale 80.13 3,672 294,223 1,157,562 Jul 19 04:09 PM Stamoulis Christiana Director Jul 17 '24 Option Exercise 26.74 9,039 241,703 54,511 Jul 19 04:06 PM Stamoulis Christiana Director Jul 17 '24 Sale 79.50 9,039 718,600 45,472 Jul 19 04:06 PM
